The observed normalization of this dysfunctional immune response to viral activation by IFN further suggests correction by rintatolimod of a viral initiation phenomena in CFS/ME. This evidence concerns the gene IFNA1 and myalgic encephalomeyelitis/chronic fatigue syndrome.